KERANETICS: Announces KeraStat® Cream product cleared by FDA for radiation dermatitis
KeraNetics Inc. announces today that the next product in its KeraStat® wound dressing portfolio, KeraStat® Cream, has been cleared by the US Food and Drug Administration for indications of radiation dermatitis.